Systemic treatment options in bladder cancer

Systemic treatment options in bladder cancer

Since the 1980's, with the advent of MVAC (methotrexate, cisplatin, vinblastine, adriamycin) the role of chemotherapy for bladder cancer was defined. Since then, multiple chemotherapy regimens have been used and the field of chemotherapy has reached a therapeutic plateau. In the last decade, th...

Full description

Bibliographic Details
Main Authors: Rahul Ravind, Kumar Prabhash, Amit Joshi, Vijay Patil, Vanita Noronha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
bladder cancer
chemotherapy
immunotherapy
muscle invasive
mibc
transitional cell
urothelial
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2018;volume=1;issue=2;spage=98;epage=109;aulast=

Internet

http://www.crstonline.com/article.asp?issn=2590-3233;year=2018;volume=1;issue=2;spage=98;epage=109;aulast=

Similar Items